Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × EBV Lymphomas × Ganciclovir × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Vulvar Neoplasms 1 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Penile Neoplasms 1 Melanoma 1 Lymphoproliferative Disorders 1 EBV Lymphomas 1 Breast Neoplasms 1 Anus Neoplasms 1

Interventions

arginine butyrate 1 Valganciclovir 1 Ganciclovir 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00917826 2011-08-01

Study of Arginine Butyrate and Ganciclovir/Valganciclovir in EBV(+) Lymphoid Malignancies

HemaQuest Pharmaceuticals Inc.

Phase 2 Terminated

EBV Lymphomas

Data powered by HemOnc (CC BY 4.0) Colophon ⚡